Previous Article | Next Article 
Journal of Virology, October 2003, p. 10689-10694, Vol. 77, No. 19
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.19.10689-10694.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Dynamics of Subgenomic Hepatitis C Virus Replicon RNA Levels in Huh-7 Cells after Exposure to Nucleoside Antimetabolites
Lieven J. Stuyver,1* Tamara R. McBrayer,1 Phillip M. Tharnish,1 Abdalla E. A. Hassan,1 Chung K. Chu,2 Krzysztof W. Pankiewicz,1 Kyochi A. Watanabe,1 Raymond F. Schinazi,3 and Michael J. Otto1
Pharmasset, Inc., Tucker, Georgia 30084,1
College of Pharmacy, University of Georgia, Athens, Georgia 30602,2
Veterans Affairs Medical Center and Department of Pediatrics, Emory University School of Medicine, Decatur, Georgia 300333
Received 15 May 2003/
Accepted 10 July 2003
Treatment with antimetabolites results in chemically induced low nucleoside triphosphate pools and cell cycle arrest in exponentially growing cells. Since steady-state levels of hepatitis C virus (HCV) replicon RNA were shown to be dependent on exponential growth of Huh-7 cells, the effects of antimetabolites for several nucleoside biosynthesis pathways on cell growth and HCV RNA levels were investigated. A specific anti-HCV replicon effect was defined as (i) minimal interference with the exponential cell growth, (ii) minimal reduction in cellular host RNA levels, and (iii) reduction of the HCV RNA copy number per cell compared to that of the untreated control. While most antimetabolites caused a cytostatic effect on cell growth, only inhibitors of the de novo pyrimidine ribonucleoside biosynthesis mimicked observations seen in confluent replicon cells, i.e., cytostasis combined with a sharp decrease in replicon copy number per cell. These results suggest that high levels of CTP and UTP are critical parameters for maintaining the steady-state level replication of HCV replicon in Huh-7 cells.
* Corresponding author. Mailing address: Pharmasset, Inc., 1860 Montreal Rd., Tucker, GA 30084. Phone: (678) 395-0050. Fax: (678) 395-0030. E-mail:
lstuyver{at}pharmasset.com.
Journal of Virology, October 2003, p. 10689-10694, Vol. 77, No. 19
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.19.10689-10694.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Borawski, J., Troke, P., Puyang, X., Gibaja, V., Zhao, S., Mickanin, C., Leighton-Davies, J., Wilson, C. J., Myer, V., CornellaTaracido, I., Baryza, J., Tallarico, J., Joberty, G., Bantscheff, M., Schirle, M., Bouwmeester, T., Mathy, J. E., Lin, K., Compton, T., Labow, M., Wiedmann, B., Gaither, L. A.
(2009). Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication. J. Virol.
83: 10058-10074
[Abstract]
[Full Text]
-
Paeshuyse, J., Vliegen, I., Coelmont, L., Leyssen, P., Tabarrini, O., Herdewijn, P., Mittendorfer, H., Easmon, J., Cecchetti, V., Bartenschlager, R., Puerstinger, G., Neyts, J.
(2008). Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors. Antimicrob. Agents Chemother.
52: 3433-3437
[Abstract]
[Full Text]
-
Dahari, H., Ribeiro, R. M., Rice, C. M., Perelson, A. S.
(2007). Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells. J. Virol.
81: 750-760
[Abstract]
[Full Text]
-
Coelmont, L., Paeshuyse, J., Windisch, M. P., De Clercq, E., Bartenschlager, R., Neyts, J.
(2006). Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2'-C-methylcytidine, the active component of valopicitabine.. Antimicrob. Agents Chemother.
50: 3444-3446
[Abstract]
[Full Text]
-
Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T., Bartenschlager, R.
(2006). Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.. J. Virol.
80: 5308-5320
[Abstract]
[Full Text]
-
Nelson, H. B., Tang, H.
(2006). Effect of Cell Growth on Hepatitis C Virus (HCV) Replication and a Mechanism of Cell Confluence-Based Inhibition of HCV RNA and Protein Expression. J. Virol.
80: 1181-1190
[Abstract]
[Full Text]
-
Windisch, M. P., Frese, M., Kaul, A., Trippler, M., Lohmann, V., Bartenschlager, R.
(2005). Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line. J. Virol.
79: 13778-13793
[Abstract]
[Full Text]
-
Tomassini, J. E., Getty, K., Stahlhut, M. W., Shim, S., Bhat, B., Eldrup, A. B., Prakash, T. P., Carroll, S. S., Flores, O., MacCoss, M., McMasters, D. R., Migliaccio, G., Olsen, D. B.
(2005). Inhibitory Effect of 2'-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon Cells. Antimicrob. Agents Chemother.
49: 2050-2058
[Abstract]
[Full Text]
-
Pfeiffer, J. K., Kirkegaard, K.
(2005). Ribavirin Resistance in Hepatitis C Virus Replicon-Containing Cell Lines Conferred by Changes in the Cell Line or Mutations in the Replicon RNA. J. Virol.
79: 2346-2355
[Abstract]
[Full Text]
-
Hwang, D.-R., Tsai, Y.-C., Lee, J.-C., Huang, K.-K., Lin, R.-K., Ho, C.-H., Chiou, J.-M., Lin, Y.-T., Hsu, J. T. A., Yeh, C.-T.
(2004). Inhibition of Hepatitis C Virus Replication by Arsenic Trioxide. Antimicrob. Agents Chemother.
48: 2876-2882
[Abstract]
[Full Text]
-
Stuyver, L. J., McBrayer, T. R., Whitaker, T., Tharnish, P. M., Ramesh, M., Lostia, S., Cartee, L., Shi, J., Hobbs, A., Schinazi, R. F., Watanabe, K. A., Otto, M. J.
(2004). Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2'-Deoxy-2'-Fluorocytidine. Antimicrob. Agents Chemother.
48: 651-654
[Abstract]
[Full Text]